Business Description
Ascletis Pharma is a Hong Kong-based biotechnology company founded in 2013 that researches, develops, and sells pharmaceutical products across Mainland China. Its current portfolio includes approved treatments for Hepatitis C and HIV, with a broad pipeline targeting conditions such as obesity, liver disease, COVID-19, acne, and several forms of cancer. The company continues to expand its reach across both infectious and chronic diseases through a growing range of small molecule drug candidates.
